Biomarkers to Enhance Early Schizophrenia Treatment
Biomarkers to Enhance Early Schizophrenia Treatment
Recruiting · NCT06969755 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biomarkers to Enhance Early Schizophrenia Treatment | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Phase 4 | 2026-07-31 | NCT06969755 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Mental Health (NIMH) | 702 |
| Northwell Health | 107 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre for Addiction and Mental Health | Toronto | Canada | 1 |
| Feinstein Institute for Medical Research | Glen Oaks | United States | 1 |
| McLean | Belmont | United States | 1 |
| The University of Alabama at Birmingham | Birmingham | United States | 20 |
| University of California San Diego | La Jolla | United States | 54 |